Champions Oncology, Inc. SEC filings CSBR

Champions Oncology, Inc. has 655 filings in SEC EDGAR's recent list, going back to Sep 13, 1995. Its latest annual report, Form 10-K, was filed on Jul 27, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 11, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (shareholder vote results). The company's fiscal year ends on April 30.

Champions Oncology, Inc. SEC filings
Form Description Filed Period
8-K Current report
Shareholder vote results
Oct 16, 2026 Oct 14, 2026
10-Q Quarterly report Sep 11, 2026 Jul 31, 2026
8-K Current report
Results of operations
Sep 10, 2026 Sep 10, 2026
DEFA14A Additional proxy material Aug 28, 2026 —
DEF 14A Proxy statement Aug 28, 2026 Aug 27, 2026
10-K Annual report Jul 27, 2026 Apr 30, 2026
8-K Current report
Results of operations
Jul 27, 2026 Jul 27, 2026
8-K Current report
Officer or director change
Mar 30, 2026 Mar 24, 2026
10-Q Quarterly report Mar 12, 2026 Jan 31, 2026
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
10-Q Quarterly report Dec 15, 2025 Oct 31, 2025
8-K Current report
Results of operations
Dec 15, 2025 Dec 15, 2025
8-K Current report
Shareholder vote results
Oct 16, 2025 Oct 16, 2025
10-Q Quarterly report Sep 15, 2025 Jul 31, 2025
8-K Current report
Results of operations
Sep 15, 2025 Sep 15, 2025
DEFA14A Additional proxy material Aug 22, 2025 —
DEF 14A Proxy statement Aug 22, 2025 Aug 22, 2025
10-K Annual report Jul 23, 2025 Apr 30, 2025
8-K Current report
Results of operations
Jul 23, 2025 Jul 23, 2025
8-K Current report Jul 21, 2025 Jul 21, 2025
10-Q Quarterly report Mar 17, 2025 Jan 31, 2025
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
UPLOAD Letter from the SEC Mar 4, 2025 —
CORRESP Letter to the SEC Mar 3, 2025 —
UPLOAD Letter from the SEC Feb 26, 2025 —
10-Q Quarterly report Dec 16, 2024 Oct 31, 2024
8-K Current report
Results of operations
Dec 11, 2024 Dec 11, 2024
S-8 Employee stock plan registration Oct 30, 2024 —
8-K Current report
Shareholder vote results
Oct 15, 2024 Oct 14, 2024
8-K Current report
Officer or director change
Oct 3, 2024 Oct 3, 2024
10-Q Quarterly report Sep 13, 2024 Jul 31, 2024
8-K Current report
Results of operations
Sep 11, 2024 Sep 11, 2024
DEFA14A Additional proxy material Aug 27, 2024 —
DEF 14A Proxy statement Aug 27, 2024 Aug 27, 2024
10-K Annual report Jul 19, 2024 Apr 30, 2024
8-K Current report
Results of operations
Jul 18, 2024 Jul 18, 2024
10-Q Quarterly report Mar 15, 2024 Jan 31, 2024
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
10-Q Quarterly report Dec 13, 2023 Oct 31, 2023
8-K Current report
Results of operations
Dec 12, 2023 Dec 12, 2023
8-K Current report
Shareholder vote results
Oct 19, 2023 Oct 19, 2023
8-K Current report
Officer or director change
Oct 17, 2023 Oct 9, 2023
10-Q Quarterly report Sep 13, 2023 Jul 31, 2023
8-K Current report
Results of operations
Sep 13, 2023 Sep 13, 2023
DEFA14A Additional proxy material Aug 28, 2023 —
DEF 14A Proxy statement Aug 28, 2023 Aug 28, 2023
10-K Annual report Jul 24, 2023 Apr 30, 2023
8-K Current report
Results of operations
Jul 24, 2023 Jul 24, 2023
8-K Current report
Regulation FD disclosure, Other events
Apr 5, 2023 Apr 5, 2023
10-Q Quarterly report Mar 16, 2023 Jan 31, 2023
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
10-Q Quarterly report Dec 13, 2022 Oct 31, 2022
8-K Current report
Results of operations
Dec 13, 2022 Dec 13, 2022
8-K Current report
Shareholder vote results
Oct 20, 2022 Oct 20, 2022
10-Q Quarterly report Sep 12, 2022 Jul 31, 2022
8-K Current report
Results of operations
Sep 8, 2022 Sep 8, 2022
DEF 14A Proxy statement Aug 31, 2022 Aug 29, 2022
DEF 14A Proxy statement Aug 29, 2022 Aug 29, 2022
DEFC14A Filing Aug 29, 2022 —
10-K Annual report Jul 22, 2022 Apr 30, 2022
8-K Current report
Results of operations
Jul 21, 2022 Jul 21, 2022
10-Q Quarterly report Mar 15, 2022 Jan 31, 2022
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
10-Q Quarterly report Dec 13, 2021 Oct 31, 2021
8-K Current report
Results of operations
Dec 13, 2021 Dec 13, 2021
8-K Current report
Shareholder vote results
Oct 21, 2021 Oct 20, 2021
10-Q Quarterly report Sep 13, 2021 Jul 31, 2021
8-K Current report
Results of operations
Sep 13, 2021 Sep 13, 2021
DEFA14A Additional proxy material Sep 1, 2021 —
DEF 14A Proxy statement Aug 30, 2021 Aug 30, 2021
10-K Annual report Jul 26, 2021 Apr 30, 2021
8-K Current report
Results of operations
Jul 22, 2021 Jul 22, 2021
10-Q Quarterly report Mar 15, 2021 Jan 31, 2021
8-K Current report
Results of operations
Mar 11, 2021 Mar 5, 2021
8-K Current report
Officer or director change
Feb 12, 2021 Feb 12, 2021
10-Q Quarterly report Dec 14, 2020 Oct 31, 2020
8-K Current report
Results of operations
Dec 14, 2020 Dec 14, 2020
8-K Current report
Shareholder vote results
Oct 21, 2020 Oct 21, 2020
8-K Current report Oct 15, 2020 Oct 15, 2020
10-Q Quarterly report Sep 14, 2020 Jul 31, 2020
8-K Current report
Results of operations
Sep 14, 2020 Sep 14, 2020
DEFA14A Additional proxy material Sep 11, 2020 —
DEFM14A Filing Sep 11, 2020 —
DEF 14A Proxy statement Aug 28, 2020 Apr 30, 2020
10-K Annual report Jul 28, 2020 Apr 30, 2020
8-K Current report
Results of operations
Jul 27, 2020 Jul 27, 2020
8-K Current report
Unregistered share sale
Mar 30, 2020 Mar 26, 2020
10-Q Quarterly report Mar 16, 2020 Jan 31, 2020
8-K Current report
Results of operations
Mar 12, 2020 Jan 31, 2020
8-K Current report
Regulation FD disclosure
Jan 3, 2020 Jan 3, 2020
10-Q Quarterly report Dec 16, 2019 Oct 31, 2019
8-K Current report
Results of operations
Dec 16, 2019 Dec 16, 2019
8-K Current report
Shareholder vote results
Oct 16, 2019 Oct 16, 2019
10-Q Quarterly report Sep 16, 2019 Jul 31, 2019
8-K Current report
Results of operations
Sep 16, 2019 Sep 16, 2019
8-K Current report
Regulation FD disclosure
Sep 5, 2019 Sep 5, 2019
DEF 14A Proxy statement Aug 28, 2019 Apr 30, 2019
10-K Annual report Jul 29, 2019 Apr 30, 2019
8-K Current report
Results of operations
Jul 15, 2019 Jul 15, 2019
10-Q Quarterly report Mar 18, 2019 Jan 31, 2019
8-K Current report
Results of operations
Mar 18, 2019 Mar 18, 2019
8-K Current report
Regulation FD disclosure
Jan 7, 2019 Jan 7, 2019
10-Q Quarterly report Dec 17, 2018 Oct 31, 2018
8-K Current report
Results of operations
Dec 17, 2018 Dec 17, 2018
8-K Current report
Shareholder vote results
Oct 16, 2018 Oct 16, 2018
10-Q Quarterly report Sep 14, 2018 Jul 31, 2018
8-K Current report
Results of operations
Sep 13, 2018 Sep 13, 2018
DEF 14A Proxy statement Aug 28, 2018 Apr 30, 2018
10-K Annual report Jul 30, 2018 Apr 30, 2018
8-K Current report
Results of operations
Jul 26, 2018 Jul 26, 2018
10-Q Quarterly report Mar 19, 2018 Jan 31, 2018
8-K Current report
Results of operations
Mar 15, 2018 Mar 15, 2018
8-K Current report
Regulation FD disclosure
Mar 12, 2018 Mar 12, 2018
10-Q Quarterly report Dec 15, 2017 Oct 31, 2017
8-K Current report
Results of operations
Dec 7, 2017 Dec 7, 2017
8-K Current report
Shareholder vote results
Oct 16, 2017 Oct 16, 2017
8-K Current report
Other events
Oct 4, 2017 Oct 4, 2017
10-Q Quarterly report Sep 14, 2017 Jul 31, 2017
8-K Current report
Results of operations
Sep 14, 2017 Sep 14, 2017
DEFR14A Filing Aug 31, 2017 —
DEF 14A Proxy statement Aug 28, 2017 Apr 30, 2017
10-K Annual report Jul 28, 2017 Apr 30, 2017
8-K Current report
Results of operations
Jul 27, 2017 Jul 27, 2017
8-K Current report
Bylaw or fiscal year change
May 9, 2017 May 9, 2017
8-K Current report
Listing notice
Apr 28, 2017 Apr 28, 2017
10-Q Quarterly report Mar 17, 2017 Jan 31, 2017
8-K Current report
Results of operations
Mar 16, 2017 Mar 16, 2017
8-K Current report
Officer or director change
Jan 26, 2017 Jan 26, 2017
10-Q Quarterly report Dec 14, 2016 Oct 31, 2016
8-K Current report
Results of operations, Officer or director change
Nov 29, 2016 Nov 29, 2016
8-K Current report
Officer or director change
Nov 1, 2016 Oct 28, 2016
8-K Current report
Shareholder vote results
Oct 14, 2016 Oct 13, 2016
10-Q Quarterly report Sep 14, 2016 Jul 31, 2016
8-K Current report
Results of operations
Sep 9, 2016 Sep 9, 2016
DEF 14A Proxy statement Aug 25, 2016 Oct 13, 2016
10-K Annual report Jul 29, 2016 Apr 30, 2016
8-K Current report Jul 28, 2016 Jul 28, 2016
8-K Current report
Officer or director change
Jul 22, 2016 Jul 19, 2016
8-K Current report
Material agreement, Other events
Jun 15, 2016 Jun 9, 2016
424B4 Prospectus Jun 10, 2016 —
EFFECT Filing Jun 9, 2016 —
CORRESP Letter to the SEC Jun 8, 2016 —
CORRESP Letter to the SEC Jun 8, 2016 —
S-1/A Amended registration statement May 24, 2016 —
CORRESP Letter to the SEC May 23, 2016 —
8-K Current report
Regulation FD disclosure
May 18, 2016 May 18, 2016
UPLOAD Letter from the SEC May 5, 2016 —
S-1 Registration statement Apr 26, 2016 —
8-K Current report
Officer or director change, Other events
Apr 13, 2016 Apr 11, 2016
8-K Current report
Listing notice
Mar 25, 2016 Mar 21, 2016
10-Q Quarterly report Mar 16, 2016 Jan 31, 2016
8-K Current report
Results of operations
Mar 15, 2016 Mar 15, 2016
8-K Current report
Regulation FD disclosure
Mar 7, 2016 Mar 7, 2016
10-Q Quarterly report Dec 15, 2015 Oct 31, 2015
8-K Current report
Results of operations
Dec 14, 2015 Dec 14, 2015
8-K Current report
Listing notice
Oct 29, 2015 Oct 26, 2015
8-K Current report
Shareholder vote results
Oct 15, 2015 Oct 13, 2015
424B3 Prospectus Oct 15, 2015 —
EFFECT Filing Oct 13, 2015 —
POS AM Filing Sep 25, 2015 —
10-Q Quarterly report Sep 11, 2015 Jul 31, 2015
8-K Current report
Results of operations
Sep 10, 2015 Sep 10, 2015
DEFR14A Form defr14a Sep 1, 2015 —
8-K Current report
Officer or director change
Aug 31, 2015 Aug 28, 2015
DEFA14A Additional proxy material Aug 31, 2015 —
DEF 14A Proxy statement Aug 28, 2015 Oct 13, 2015
8-K Current report
Other events
Aug 21, 2015 Aug 21, 2015
CERTNAS Auto-generated paper document Aug 20, 2015 —
8-A12B Form 8-a12b Aug 20, 2015 —
8-K Current report
Bylaw or fiscal year change, Other events
Aug 13, 2015 Aug 11, 2015
10-K Annual report Jul 29, 2015 Apr 30, 2015
8-K Current report
Results of operations
Jul 28, 2015 Jul 28, 2015
8-K Current report
Officer or director change
Jul 23, 2015 Jul 2, 2015
EFFECT Filing May 19, 2015 —
424B3 Prospectus May 19, 2015 —
S-1 Registration statement May 11, 2015 —
8-K Current report
Bylaw or fiscal year change
Apr 28, 2015 Apr 24, 2015
DEF 14C Information statement Mar 30, 2015 Mar 27, 2015
UPLOAD Letter from the SEC Mar 25, 2015 —
PRER14C Form prer14c Mar 25, 2015 —
D Filing Mar 25, 2015 —
CORRESP Letter to the SEC Mar 25, 2015 —
UPLOAD Letter from the SEC Mar 24, 2015 —
8-K Current report
Officer or director change
Mar 20, 2015 Mar 16, 2015
10-Q Quarterly report Mar 17, 2015 Jan 31, 2015
8-K Current report
Results of operations
Mar 17, 2015 Mar 17, 2015
8-K Current report
Material agreement, Unregistered share sale, Shareholder vote results
Mar 17, 2015 Mar 10, 2015
PRE 14C Form pre 14c Mar 16, 2015 Mar 13, 2015
8-K Current report
Material agreement, Unregistered share sale
Mar 12, 2015 Mar 11, 2015
8-K Current report
Material agreement, Unregistered share sale
Mar 2, 2015 Feb 28, 2015
10-Q Quarterly report Dec 15, 2014 Oct 31, 2014
D Filing Dec 12, 2014 —
8-K Current report
Results of operations
Dec 12, 2014 Dec 12, 2014
8-K Current report
Material agreement, Unregistered share sale
Dec 5, 2014 Dec 1, 2014
8-K Current report
Auditor change
Dec 1, 2014 Nov 25, 2014
8-K Current report
Shareholder vote results
Oct 14, 2014 Oct 13, 2014
10-Q Quarterly report Sep 12, 2014 Jul 31, 2014
8-K Current report
Results of operations
Sep 11, 2014 Sep 11, 2014
DEFA14A Additional proxy material Aug 29, 2014 —
DEF 14A Proxy statement Aug 28, 2014 Oct 13, 2014

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CSBR (Nasdaq)
Fiscal year ends
April 30
Incorporated in
DE
Headquarters
Baltimore, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
771856
Former names
CHAMPIONS BIOTECHNOLOGY, INC. (until Mar 30, 2011); CHAMPIONS SPORTS INC (until Feb 16, 2007)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.